EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Usana Health Sciences's enterprise value is €505.4 Mil.
Usana Health Sciences's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was €112.3 Mil. Therefore, Usana Health Sciences's EV-to-EBITDA for today is 4.50.
The historical rank and industry rank for Usana Health Sciences's EV-to-EBITDA or its related term are showing as below:
FRA:USJ'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.21 Med: 8.27 Max: 16.54
Current: 4.47
During the past 13 years, the highest EV-to-EBITDA of Usana Health Sciences was 16.54. The lowest was 4.21. And the median was 8.27.
FRA:USJ's EV-to-EBITDA is ranked better than 87.1% of 1558
companies
in the Consumer Packaged Goods industry
Industry Median: 10.685
vs FRA:USJ: 4.47
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Usana Health Sciences EV-to-EBITDA Historical Data
The historical data trend for Usana Health Sciences's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Usana Health Sciences's EV-to-EBITDA
For the Packaged Foods subindustry, Usana Health Sciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Usana Health Sciences's EV-to-EBITDA Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Usana Health Sciences's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Usana Health Sciences's EV-to-EBITDA falls into.
Usana Health Sciences's current Enterprise Value is €505.4 Mil.
Usana Health Sciences's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €112.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Usana Health Sciences (FRA:USJ) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Usana Health Sciences's PE Ratio for today is calculated as:
Usana Health Sciences's share price for today is €41.80.
Usana Health Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.963.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Usana Health Sciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Usana Health Sciences (FRA:USJ) Business Description
Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:USJ has been successfully added to your 